Therapeutic areas

Our vision is to provide innovative solutions for disabling conditions and to improve patient care – it is at the heart of everything we do.

At Ipsen, our licensed medicines and R&D cover a range of therapeutic areas. However, all are focused on curing disease and relieving suffering, hoping to bring real value to the healthcare community.

Our primary focus lies in three main areas: oncology (cancers), neurosciences (diseases of the nervous system and the use of therapeutic neurotoxins) and rare diseases.

Oncology

Oncology

Every two minutes someone in the UK is diagnosed with cancer, with someone in Ireland receiving a cancer diagnosis every 3 minutesi,ii. Ipsen is committed to developing new treatments with the ability to improve and extend lives of those affected.

iCancer Research UK: Cancer Incidence Statistics UK. Available here. Accessed January 2022.

iiIrish Cancer Society: Cancer Statistics. Available here. Accessed January 2022.

Tackling cancer head-on

Although often talked about generally, ‘cancer’ describes a diverse range of diseases (over 200 different types of cancer exist)i. Each type of cancer is typically characterised by the presence of abnormal cells that divide in an uncontrollable wayii. Some cancers can be surgically removed or treated successfully, particularly if they are detected early. However, for people with advanced or complicated cancers, treatment options can be limitediii.

iCancer Research UK: What is Cancer? Available here. Accessed January 2022.

iiCancer Research UK: Cancer Cells. Available here. Accessed January 2022.

iiiCancer Research UK: Treatment for Cancer. Available here. Accessed January 2022.

Neuroscience

Neuroscience

At Ipsen we have pioneered research in the area of neuroscience for decades and remain committed to providing patients with innovative therapeutic solutions.

Searching for solutions to debilitating neurological conditions

Neurological conditions are disorders of the brain, spinal cord and/or nerves. They can be caused by a variety of factors, such as genetic factors, traumatic injuries/accidents, the environment or infections. The causes of some of these conditions are still not well understoodi.

Some of these conditions are debilitating and many of them can severely affect a person’s quality of life.

iThe Neurological Alliance: Living with a Neurological Condition. Available here. Accessed January 2022

Rare diseases

In the EU, a disease is considered to be a rare disease when the number of people affected is no more than 1 person in 2,000.Ipsen is committed to translating scientific progress into clinically meaningful medicines for people suffering from rare conditions.

iEuropean Union: EU Research on Rare Diseases.  Available here. Accessed January 2022

Addressing areas of unmet need

Ipsen’s work in rare diseases currently focuses on a number of endocrine diseases, looking at how we can address areas of high unmet need for people affected by hormone and metabolic imbalances.

The endocrine system is comprised of a series of glands, which are each responsible for secreting a specific type of hormone into the bloodstream. These hormones have vital functions including how we balance fluid and salt in our blood vessels, maintain blood pressure, control of growth and reproduction. Endocrine diseases occur when these glands make either too more or too little of their respective hormone, or if a gland grows and develops tumours within themi.

iBarts Health NHS Trust: Endocrinology. Available here. Accessed January 2022

Other therapeutic areas

Other therapeutic areas

Every day we strive to support positive change for patients and health services across the UK, working in close partnership to deliver meaningful results. At Ipsen, our licensed medicines and R&D cover a range of therapeutic areas.

We are committed to improving quality of life for patients and discovering new solutions for targeted debilitating diseases.

ALLSC-GB-000008

August 2022

© Ipsen Group 2022